The Venture Codex Logo

The Venture Codex

Overview

Innovative therapeutic solutions in healthcare and pharmaceuticals.

Founded

1973

Deals · 12mo

7

Stage focus

Series B

Geographic focus

France
United States

Sector focus

Health Care
Life Science
Pharmaceutical
Therapeutics

Investment portfolio

28rounds
NAMEDATESIZE
InduPro
Aug 2026Participated
$77 MSeries B
Cour Pharmaceuticals Development
Jun 2026Participated
$50 MSeries B
DiappyMed
Mar 2026Participated
$6 MOther Equity
Earendil Labs
Mar 2026Participated
$787 MOther Equity
Altesa
Feb 2026Participated
$75 MSeries B
Enable Injections
Jan 2026Led
$30 MOther Equity
Electra Therapeutics
Oct 2025Participated
$183 MSeries C
MapLight Therapeutics
Jul 2025Participated
$373 MSeries D
Zucara Therapeutics
May 2025Participated
$25 MSeries B
Enveda Biosciences
Feb 2025Led
$150 MSeries C
AgomAb Therapeutics
Oct 2024Participated
$95 MSeries D
Vigil Neuroscience
Jun 2024Led
$40 MOther Equity
InduPro
Aug 2026Participated
$77 MSeries B
Cour Pharmaceuticals Development
Jun 2026Participated
$50 MSeries B
DiappyMed
Mar 2026Participated
$6 MOther Equity
Earendil Labs
Mar 2026Participated
$787 MOther Equity
Altesa
Feb 2026Participated
$75 MSeries B
Enable Injections
Jan 2026Led
$30 MOther Equity
Electra Therapeutics
Oct 2025Participated
$183 MSeries C
MapLight Therapeutics
Jul 2025Participated
$373 MSeries D
Zucara Therapeutics
May 2025Participated
$25 MSeries B
Enveda Biosciences
Feb 2025Led
$150 MSeries C
AgomAb Therapeutics
Oct 2024Participated
$95 MSeries D
Vigil Neuroscience
Jun 2024Led
$40 MOther Equity
28
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Sanofi: 28 funding rounds are recorded in the selected participation categories.All available history.
Sanofi: 28 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A22
Series B17
Series C+14
Other Equity73
Grant01

Monthly Deal Activity

Sanofi: 28 deals are recorded across 193 months.All available history.
Sanofi: 28 deals are recorded across 193 months. All available history
MonthDeals
Oct '101
Nov '100
Dec '100
Jan '110
Feb '110
Mar '110
Apr '110
May '110
Jun '111
Jul '110
Aug '110
Sep '110
Oct '110
Nov '110
Dec '110
Jan '121
Feb '120
Mar '120
Apr '120
May '120
Jun '120
Jul '120
Aug '120
Sep '120
Oct '120
Nov '120
Dec '120
Jan '130
Feb '130
Mar '130
Apr '130
May '130
Jun '130
Jul '130
Aug '130
Sep '130
Oct '130
Nov '130
Dec '130
Jan '140
Feb '140
Mar '140
Apr '140
May '140
Jun '140
Jul '140
Aug '140
Sep '140
Oct '141
Nov '140
Dec '140
Jan '150
Feb '150
Mar '150
Apr '151
May '150
Jun '150
Jul '150
Aug '150
Sep '150
Oct '150
Nov '150
Dec '150
Jan '160
Feb '160
Mar '160
Apr '160
May '160
Jun '160
Jul '160
Aug '160
Sep '161
Oct '160
Nov '160
Dec '160
Jan '170
Feb '170
Mar '170
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '191
Feb '191
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '201
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '211
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '212
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '221
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '241
Mar '240
Apr '240
May '240
Jun '243
Jul '240
Aug '240
Sep '240
Oct '241
Nov '240
Dec '240
Jan '250
Feb '251
Mar '250
Apr '250
May '251
Jun '250
Jul '251
Aug '250
Sep '250
Oct '251
Nov '250
Dec '250
Jan '261
Feb '261
Mar '262
Apr '260
May '260
Jun '261
Jul '260
Aug '261
Sep '260
Oct '260

Sector Breakdown

Sanofi: Health & Life Sciences is the largest displayed sector by deal count (28 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Sanofi: Health & Life Sciences is the largest displayed sector by deal count (28 deals). All available history
SectorDeals
Health & Life Sciences28
AI & Machine Learning4
Enterprise Software2
Manufacturing2
Data, Analytics & IT2
Networks, Cloud & Communication1
Clean Energy & Sustainability1
Consumer & Lifestyle1

Deal Size Distribution

Sanofi: 28 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Sanofi: 28 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M2
$10M-$25M3
$25M-$50M5
$50M-$100M8
$100M-$250M4
$250M-$500M3
$500M-$1B1
$1B+0

Deals By Geography

Sanofi: United States has the largest recorded deal count among the displayed regions (21 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

Sanofi: United States has the largest recorded deal count among the displayed regions (21 deals). All available history
RegionDeals
United States21
Europe6
Canada1
Sanofi: 20 co-investors are shown, with Access Biotechnology sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

Sanofi: Led accounts for 39% and participating for 61% of round participation.All available history.
Sanofi: Led accounts for 39% and participating for 61% of round participation. All available history
CategoryDeals (count)Share (%)
Led1139%
Participating1761%
Sanofi: Single-lead accounts for 91% and co-led for 9% of lead dynamics.All available history.
Sanofi: Single-lead accounts for 91% and co-led for 9% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1091%
Co-led19%

Team

Christophe Hirtz

Source to Pay project Lead

Franqui Jimenez

Business Partner Rare Disease Cluster, Global MSAT

Jean-Baptiste Chasseloup de Chatillon

Executive Vice President & CFO

Jean-Pierre Adiceom

Responsable Financier

John O'Malley

Principal Clinical Research Director and Global Clinical Lead, Amlitelimab

Lucia Cardenas Melgarejo

Global Digital Agency Relationship & Digital Marketing // Consumer Healthcare

Patricia Roselle

Global Head, Patient Network Management

Rinat Nazmutdinov

Talent Acquisition Partner (Digital, Data & AI)